35 related articles for article (PubMed ID: 10665869)
1. Psychiatric complications in Graves' disease.
Holmberg M; Malmgren H; Berglund PF; Johansson B; Nyström HF
Eur Thyroid J; 2024 Feb; 13(1):. PubMed ID: 38215285
[TBL] [Abstract][Full Text] [Related]
2. Using Bedside Spectral Doppler Ultrasound for the Assessment of Patients With Thyrotoxicosis.
Morkos M; Raju KD; Ibrahim K
Endocr Pract; 2024 May; 30(5):465-469. PubMed ID: 38331386
[TBL] [Abstract][Full Text] [Related]
3. Graves on the Relapse Periods of Ague, and the Indications of Treatment.
West J Med Surg; 1846 Jul; 6(1):78-79. PubMed ID: 38209048
[No Abstract] [Full Text] [Related]
4. Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management.
Wang J; Wan K; Chang X; Mao RF
World J Diabetes; 2024 Mar; 15(3):348-360. PubMed ID: 38591076
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease.
Kwon H; Kim WG; Jang EK; Kim M; Park S; Jeon MJ; Kim TY; Ryu JS; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2016 Jun; 31(2):300-10. PubMed ID: 27118279
[TBL] [Abstract][Full Text] [Related]
6. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
7. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome.
Castagnone D; Rivolta R; Rescalli S; Baldini MI; Tozzi R; Cantalamessa L
AJR Am J Roentgenol; 1996 Jan; 166(1):203-7. PubMed ID: 8571877
[TBL] [Abstract][Full Text] [Related]
8. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
[TBL] [Abstract][Full Text] [Related]
9. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
[TBL] [Abstract][Full Text] [Related]
10. [Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease].
Amodio F; Di Martino S; Esposito S; Iorio S; Hierholzer J; Rea G; Bizzarro A; Vallone G
Radiol Med; 2001 Oct; 102(4):233-7. PubMed ID: 11740450
[TBL] [Abstract][Full Text] [Related]
11. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
[TBL] [Abstract][Full Text] [Related]
12. Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease.
Varsamidis K; Varsamidou E; Mavropoulos G
Acta Radiol; 2000 Jan; 41(1):45-8. PubMed ID: 10665869
[TBL] [Abstract][Full Text] [Related]
13. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
